Invention Grant
- Patent Title: Pertussis vaccines and methods of making and using
-
Application No.: US15474594Application Date: 2017-03-30
-
Publication No.: US10799573B2Publication Date: 2020-10-13
- Inventor: Timothy Joseph Brickman , Sandra Kay Armstrong
- Applicant: Regents of the University of Minnesota
- Applicant Address: US MN Minneapolis
- Assignee: Regents of the University of Minnesota
- Current Assignee: Regents of the University of Minnesota
- Current Assignee Address: US MN Minneapolis
- Agency: Fish & Richardson P.C.
- Main IPC: A61K39/10
- IPC: A61K39/10 ; A61K39/00 ; A61K39/02 ; C07K14/235 ; C12N1/20
Abstract:
Bordetella pertussis iron receptor proteins or portions thereof (e.g., one or more extracellular domains), alone or spliced into B. pertussis scaffold proteins (e.g., fimbrial or flagellin), are provided and can be used in acellular vaccines to protect against pertussis or other Bordetella diseases in humans and non-human mammals. In addition, Bordetella species grown under iron-starved conditions are provided and can be used in whole cell vaccines to protect against pertussis or other Bordetella diseases in humans and non-human mammals.
Public/Granted literature
- US20170333547A1 PERTUSSIS VACCINES AND METHODS OF MAKING AND USING Public/Granted day:2017-11-23
Information query
